Clinical Trials Logo

Myalgia clinical trials

View clinical trials related to Myalgia.

Filter by:

NCT ID: NCT01912469 Completed - Clinical trials for Exercise-induced Muscle Soreness

Effects of Traumeel®S Tablets on Exercise Induced Muscle Damage and Muscle Soreness

Start date: April 2010
Phase: Phase 1
Study type: Interventional

To investigate and compare the effects of Traumeel®S tablets versus placebo on exercise induced muscle damage and muscle soreness for 72 hours after strenuous eccentric exercise test on downhill treadmill.

NCT ID: NCT01845558 Completed - Muscle Soreness Clinical Trials

Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise

2012-005003-40
Start date: February 2013
Phase: Phase 4
Study type: Interventional

The aim of the current study is to investigate the therapeutic effect and especially the mode of action of Wobenzym® plus, an anti-inflammatory drug containing proteolytic enzymes, on exercise induced muscle damage (eiMD) and recovery time in male amateur sportsmen with medium proficiency level compared to placebo.

NCT ID: NCT01827696 Completed - Muscle Damage Clinical Trials

Effect of American Ginseng on Exercise-induced Muscle Soreness

Start date: May 2013
Phase: Phase 1
Study type: Interventional

Healthy participants will ingest American ginseng daily or a placebo for four weeks prior to engaging in a unaccustomed exercise bout designed to induce mild-moderate muscle soreness. Muscle soreness will be assessed via decrements in muscle strength and with a self-rating of perceived soreness before and several times after the exercise.

NCT ID: NCT01825616 Completed - Muscle Soreness Clinical Trials

Vitamin D2, Muscle Damage, NASCAR Pitcrew

Start date: October 2012
Phase: N/A
Study type: Interventional

Hypothesis: Six weeks of supplementation with vitamin D (4000 IU/day) using Dole's Vitamin D Portobello Mushroom Powder will increase winter serum vitamin D levels, and improve muscle function and strength, and innate immunity (granulocyte/monocyte phagocytosis and oxidative burst activity), and attenuate exercise-induced muscle damage and DOMS.

NCT ID: NCT01781910 Completed - Clinical trials for Exercise-induced Delayed Onset Muscle Soreness

Branched Chain Amino Acid Plus Glucose Supplement Reduces Exercise-Induced Delayed Onset Muscle Soreness in College Females

Start date: September 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if a dietary supplement containing branched chain amino acids will reduce the muscle soreness that sometimes occurs in the days following exercise.

NCT ID: NCT01730495 Terminated - Clinical trials for Chronic Fatigue Syndrome

Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome

Start date: October 2012
Phase: Phase 2
Study type: Interventional

The hypothesis is that a subset of patients with chronic fatigue syndrome/ myalgic encephalomyelitis (CFS/ME), including also patients with no clinical response after B-cell depletion therapy using the anti-CD20 antibody Rituximab, may benefit from tumor necrosis factor-alpha inhibition using Etanercept as weekly subcutaneous injections.

NCT ID: NCT01586286 Withdrawn - Clinical trials for Levator Ani Syndrome

A Study Examining the Use of Vaginal Nifedipine With Pelvic Floor Physical Therapy for Levator Myalgia and Pelvic Pain

Start date: July 2012
Phase: N/A
Study type: Interventional

The objective of this study is to perform a randomized controlled trial among female patients with a diagnosis of pelvic floor hypertonus (extreme muscle tension) with associated pain, dysfunctional voiding, dyspareunia, and/ or obstructed defecation.

NCT ID: NCT01509079 Completed - Joint Pain Clinical Trials

Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors

Start date: March 2012
Phase: Phase 2
Study type: Interventional

The Purpose of this study is to determine whether vitamin D3 supplements will decrease the muscle and bone pain that are reported by women who take Aromatase Inhibitors.

NCT ID: NCT01506583 Completed - Fatigue Clinical Trials

Clinical Evaluation of QFlu Combo Test

QFlu
Start date: November 1, 2010
Phase:
Study type: Observational

Currently effective antivials for influenza treatment are two influenza viral neuraminidase inhibitors, oseltamivir (Tamiflu) and zanamivir (Relenza). Resistance to these drugs is reflected by reduced susceptibility of viral neuraminidase to these drugs. The hypothesis is that the signal ratio of two reagents (with or without a single concentration of the drug) correlates the IC50 value, an accurate measurement of drug resistance but impractical for clinical use.

NCT ID: NCT01279590 Completed - Clinical trials for Hypercholesterolemia

Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

Start date: March 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the incidence of statin-associated myalgia (SAM) with treatment with PPD10558 versus atorvastatin in patients previously intolerant to statins. To assess the safety and tolerability of PPD10558 compared to atorvastatin in patients previously intolerant to statins.